Latest News and Press Releases

Ottawa, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The CDMO services market for pharma and biotech is witnessing remarkable growth between 2024 and 2034, fueled by the rising trend of outsourcing among...

IntoCell and Xcellon Biologics partner to expand ADC development access, combining IntoCell's OHPAS payload-linker platform with Xcellon's CDMO expertise.

CHASKA, Minn., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...

Lifecore to Execute Commercial Site Transfer and Become New Supplier of Choice for Leading Commercial Injectable Pharmaceutical Product Represents Second Agreement Signed with Same Major...

ALBANY, N.Y., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced the release of its third...

CHASKA, Minn. and TORRANCE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization...

Curia's $4 million investment upgrades its sterile API manufacturing facility in Valladolid, Spain, to align with EU GMP Annex 1 standards.

OXB to participate in upcoming investor conferences and events Oxford, UK – 27 October 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces that...

Apeloa Pharmaceutical showcases advanced technology & integrated solutions at CPHI Frankfurt 2025

Dublin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The "U.S. Investigational New Drug CDMO Market Size, Share & Trends Analysis Report by Service (Contract Development, Contract Manufacturing), End Use...